Anthem Biosciences IPO Financials
The Anthem Biosciences IPO provide an overview of the company's performance over the previous financial periods. Investors can evaluate key financial metrics such as assets, revenue, profit after tax (PAT), net worth, reserves & surplus, and total borrowings to assess the company's financial strength, profitability, and long-term growth potential before investing in the IPO.
As of 31 Mar 2025, Anthem Biosciences Limited reported assets of ₹2,807.58 crore, revenue of ₹1,930.29 crore, and a profit after tax (PAT) of ₹451.26 crore. The company had a net worth of ₹2,409.86 crore and reserves & surplus of ₹2,298.05 crore, and total borrowings are 108.95 crore.
Revenue decreased by 23.17% in 31 Mar 2024 and decreased by 23.54% in 31 Mar 2023, while Profit After Tax (PAT) declined by 18.60% in 31 Mar 2024 and grew by 4.87% in 31 Mar 2023, respectively.
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Anthem Biosciences Limited Financials (₹ in Crores)
| Particular | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 2807.58 | 2398.11 | 2014.46 |
| Revenue | 1930.29 | 1483.07 | 1133.99 |
| Profit After Tax | 451.26 | 367.31 | 385.19 |
| Net Worth | 2409.86 | 1924.66 | 1740.67 |
| Reserve & Surplus | 2298.05 | 1815.39 | 1628.88 |
| Total Borrowings | 108.95 | 232.53 | 125.06 |
EPS Pre
8.07%
EPS Post
8.07%
P/E Pre
70.62
P/E (Post Issue)
70.62x
Company Financial Information
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Revenue of Anthem Biosciences Limited?
Anthem Biosciences Limited reported revenue of ₹1930.29 crore as of 31 Mar 2025. Revenue figures from the Anthem Biosciences IPO provide insights into sales growth, market demand, and business scalability.
What is the Profit After Tax (PAT) of Anthem Biosciences Limited?
Anthem Biosciences Limited reported a Profit After Tax (PAT) of ₹451.26 crore as of 31 Mar 2025. PAT represents the company's net profit after deducting all operating expenses, interest, taxes, and other applicable charges, making it a key indicator of overall profitability.
What is the PE Ratio of Anthem Biosciences Limited?
Anthem Biosciences Limited has a Price-to-Earnings (P/E) ratio of 70.62x based on the IPO issue price. The P/E ratio compares the company's share price with its earnings per share (EPS) and is a commonly used valuation metric to assess whether a stock is fairly valued relative to its earnings and industry peers.